| |
|
|
 |
- Address:
- 2000 Sierra Point Parkway, # 400
Brisbane, CA 94005
- Phone:
- (650) 624-4900
- Website:
- http://www.tercica.com
-
- Company Information:
-
Tercica, Inc., based in Brisbane, Calif, is a biopharmaceutical company committed to improving endocrine health.
Tercica is helping patients by partnering with the endocrine community to develop and commercialize new therapeutics for short stature, our initial market opportunity, and associated metabolic disorders.
Tercica's flagship product is Increlex™ (mecasermin [rDNA origin] injection), or recombinant human Insulin-like Growth Factor-1 (rhIGF-1). Increlex is indicated for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone
|
 |
|
|
